Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors-Reference-Cited by-同舟云学术

Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors

Published:2001-04 Issue:1-2 Volume:417 Page:11-18
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ezeamuzie Charles I

Publisher

Elsevier BV

Subject

Pharmacology

Reference34 articles.

1. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol;Au;Br. J. Pharmacol.,1998

2. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea pigs;Banner;Br. J. Pharmacol.,1995

3. New concepts in pathogenesis of bronchial hyperresponsiveness and asthma;Barnes;J. Allergy Clin. Immunol.,1989

4. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase inhibitor: in vitro anti-inflammatory actions;Barnette;J. Pharmacol. Exp. Ther.,1998

5. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms;Beavo;Physiol. Rev.,1995

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions;Current Medicinal Chemistry;2016-01-14

2. Osthol attenuates neutrophilic oxidative stress and hemorrhagic shock-induced lung injury via inhibition of phosphodiesterase 4;Free Radical Biology and Medicine;2015-12

3. Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination Therapies;Phosphodiesterases as Drug Targets;2011

4. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells;European Journal of Pharmacology;2007-07

5. Theophylline and Dexamethasone Induce Peroxisome Proliferator-Activated Receptor-γ Expression in Human Eosinophils;Pharmacology;2006